vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and Richmond Mutual Bancorporation, Inc. (RMBI). Click either name above to swap in a different company.
Gossamer Bio, Inc. is the larger business by last-quarter revenue ($13.8M vs $13.1M, roughly 1.1× Richmond Mutual Bancorporation, Inc.). Richmond Mutual Bancorporation, Inc. runs the higher net margin — 26.1% vs -342.3%, a 368.4% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 18.1%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
Richmond Mutual Bancorporation, Inc. is a U.S.-based bank holding company operating primarily in Indiana. It offers a full range of personal and commercial banking solutions including deposit accounts, mortgage loans, small business lending, and wealth management services, serving local retail consumers and small-to-medium enterprise clients via its regional branch network.
GOSS vs RMBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $13.1M |
| Net Profit | $-47.2M | $3.4M |
| Gross Margin | — | — |
| Operating Margin | -333.6% | — |
| Net Margin | -342.3% | 26.1% |
| Revenue YoY | 47.1% | 18.1% |
| Net Profit YoY | -43.0% | 37.7% |
| EPS (diluted) | $-0.21 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $13.1M | ||
| Q3 25 | $13.3M | $12.6M | ||
| Q2 25 | — | $11.8M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $11.1M | ||
| Q3 24 | — | $10.8M | ||
| Q2 24 | $95.8M | $10.7M | ||
| Q1 24 | $0 | $11.0M |
| Q4 25 | $-47.2M | $3.4M | ||
| Q3 25 | $-48.2M | $3.6M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | $2.0M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | $49.2M | $2.1M | ||
| Q1 24 | $-41.9M | $2.4M |
| Q4 25 | -333.6% | — | ||
| Q3 25 | -369.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | -342.3% | 26.1% | ||
| Q3 25 | -362.7% | 28.6% | ||
| Q2 25 | — | 22.0% | ||
| Q1 25 | — | 17.2% | ||
| Q4 24 | — | 22.4% | ||
| Q3 24 | — | 23.0% | ||
| Q2 24 | 51.4% | 19.3% | ||
| Q1 24 | — | 21.6% |
| Q4 25 | $-0.21 | $0.35 | ||
| Q3 25 | $-0.21 | $0.36 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.20 | ||
| Q4 24 | — | $0.25 | ||
| Q3 24 | — | $0.24 | ||
| Q2 24 | $0.22 | $0.20 | ||
| Q1 24 | $-0.19 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $33.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-122.8M | $145.8M |
| Total Assets | $172.2M | $1.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $33.1M | ||
| Q3 25 | $180.2M | $34.3M | ||
| Q2 25 | — | $27.2M | ||
| Q1 25 | — | $27.0M | ||
| Q4 24 | — | $21.8M | ||
| Q3 24 | — | $19.6M | ||
| Q2 24 | $354.5M | $19.0M | ||
| Q1 24 | $244.4M | $20.3M |
| Q4 25 | $-122.8M | $145.8M | ||
| Q3 25 | $-82.3M | $140.0M | ||
| Q2 25 | — | $132.3M | ||
| Q1 25 | — | $130.9M | ||
| Q4 24 | — | $132.9M | ||
| Q3 24 | — | $140.0M | ||
| Q2 24 | $81.5M | $131.1M | ||
| Q1 24 | $26.7M | $132.4M |
| Q4 25 | $172.2M | $1.5B | ||
| Q3 25 | $208.8M | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | $373.4M | $1.5B | ||
| Q1 24 | $259.4M | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $16.0M |
| Free Cash FlowOCF − Capex | — | $14.6M |
| FCF MarginFCF / Revenue | — | 111.9% |
| Capex IntensityCapex / Revenue | 0.0% | 10.4% |
| Cash ConversionOCF / Net Profit | — | 4.68× |
| TTM Free Cash FlowTrailing 4 quarters | — | $26.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $16.0M | ||
| Q3 25 | $-36.2M | $6.3M | ||
| Q2 25 | — | $4.8M | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | — | $14.8M | ||
| Q3 24 | — | $2.9M | ||
| Q2 24 | $116.3M | $2.9M | ||
| Q1 24 | $-52.3M | $2.2M |
| Q4 25 | — | $14.6M | ||
| Q3 25 | — | $5.8M | ||
| Q2 25 | — | $4.2M | ||
| Q1 25 | — | $2.1M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | — | $2.8M | ||
| Q2 24 | — | $2.8M | ||
| Q1 24 | — | $2.0M |
| Q4 25 | — | 111.9% | ||
| Q3 25 | — | 46.2% | ||
| Q2 25 | — | 35.6% | ||
| Q1 25 | — | 18.4% | ||
| Q4 24 | — | 129.3% | ||
| Q3 24 | — | 25.7% | ||
| Q2 24 | — | 26.2% | ||
| Q1 24 | — | 18.7% |
| Q4 25 | 0.0% | 10.4% | ||
| Q3 25 | 0.0% | 3.7% | ||
| Q2 25 | — | 5.3% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | 0.0% | 1.1% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | — | 4.68× | ||
| Q3 25 | — | 1.75× | ||
| Q2 25 | — | 1.86× | ||
| Q1 25 | — | 1.11× | ||
| Q4 24 | — | 5.96× | ||
| Q3 24 | — | 1.17× | ||
| Q2 24 | 2.36× | 1.42× | ||
| Q1 24 | — | 0.91× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
